Vaccination to prevent T cell subversion can protect against persistent hepacivirus infection

Nat Commun. 2019 Mar 7;10(1):1113. doi: 10.1038/s41467-019-09105-0.

Abstract

Efforts to develop an effective vaccine against the hepatitis C virus (HCV; human hepacivirus) have been stymied by a lack of small animal models. Here, we describe an experimental rat model of chronic HCV-related hepacivirus infection and its response to T cell immunization. Immune-competent rats challenged with a rodent hepacivirus (RHV) develop chronic viremia characterized by expansion of non-functional CD8+ T cells. Single-dose vaccination with a recombinant adenovirus vector expressing hepacivirus non-structural proteins induces effective immunity in majority of rats. Resolution of infection coincides with a vigorous recall of intrahepatic cellular responses. Host selection of viral CD8 escape variants can subvert vaccine-conferred immunity. Transient depletion of CD8+ cells from vaccinated rats prolongs infection, while CD4+ cell depletion results in chronic viremia. These results provide direct evidence that co-operation between CD4+ and CD8+ T cells is important for hepacivirus immunity, and that subversion of responses can be prevented by prophylactic vaccination.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CD4-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / immunology
  • Disease Models, Animal
  • Female
  • Hepacivirus / immunology
  • Hepatitis C, Chronic / immunology*
  • Hepatitis C, Chronic / prevention & control*
  • Humans
  • Immune Evasion
  • Immunity, Cellular
  • Lymphocyte Depletion
  • Male
  • Rats
  • Rats, Inbred Lew
  • T-Lymphocytes / immunology*
  • Vaccines, Synthetic / pharmacology
  • Viral Hepatitis Vaccines / pharmacology*
  • Viremia / immunology
  • Viremia / prevention & control

Substances

  • Vaccines, Synthetic
  • Viral Hepatitis Vaccines